HOME >> BIOLOGY >> NEWS
Award supports Virginia Tech research to reduce vehicle emissions, create biofuel

ture, and also lag the development of lignocellulose pretreatment and cellulase improvement," Zhang said.

His new research, in collaboration with Mike Himmel at the National Renewable Energy Laboratory and Jonathan Mielenz at ORNL, Zhang will develop a new nano-scale tool to determine cellulose accessibility to the digesting enzymes and measure the fraction and concentration of the enzymes on the cellulose surface. The research will go on to quantitatively determine substrate characteristics and their impacts on the activities of the enzymes. "It will foster research on improvements in cellulase activity and biomass pretreatment to make bioethanol processes more efficient and economical," Zhang said.

Zhang received his undergraduate degree and his master of science degree in biochemical engineering at the East China University of Science and Technology in Shanghai, and his Ph.D. in biochemical and chemical engineering from the Thayer School of Engineering at Dartmouth College, where he was also a post-doctoral associate and a research scientist. He joined the Virginia Tech faculty in 2005. His research interests are bioenergy and biobased products, including production of ethanol and other chemicals, biocatalysis and protein engineering, environmental biotechnology, and bionanotechnology. He has established a basic molecular biology and bioprocess laboratory at Virginia Tech. He will teach thermodynamics in Fall 2006.

Learn more about Zhang's work at filebox.vt.edu/users/ypzhang/research.htm.


'"/>

Contact: Susan Trulove
STrulove@vt.edu
540-231-5646
Virginia Tech
3-May-2006


Page: 1 2 3 4

Related biology news :

1. Awards celebrating women and biotech brilliance
2. Serica scientists win AOSSM Award for ACL (knee) tissue regeneration in preclinical study
3. ASM scores a hat-trick at the 2007 Hermes Creative Awards
4. Developer of new method for treating bone defects wins WPI Entrepreneurship Award
5. Ossurs PROPRIO FOOT takes the Gold 2007 Medical Design Excellence Award
6. Michael R. Zalutsky receives SNMs 2007 Paul C. Aebersold Award
7. SNM recognizes R. Edward Coleman with 2007 Georg Charles de Hevesy Nuclear Pioneer Award
8. Scientists honored with Excellence in Clinical Research Award
9. 2007 Alzheimer Award to Jing Zhang, M.D., Ph.D.
10. Weill Cornell pharmacologist receives prestigious NIH MERIT Award
11. JDRF announces 2007 Scholar Award recipients

Post Your Comments:
(Date:7/8/2015)... July 8, 2015 Summary Pancreatic cancer ... fourth most fatal, with a mortality rate of 10.9 ... of pancreatic cancer patients has highlighted a significant need ... not being met by the current market. A ... products with varying molecule types and mechanisms of action, ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
(Date:6/30/2015)... YORK , June 30, 2015 To bolster ... security provider HYPR Corp. announced today the addition of two ... will serve as board advisor and David Raviv ... the team underscore HYPR Corp.,s commitment to providing the most ... Dimitri Sirota co-founded Layer 7 Technologies, a provider ...
Breaking Biology News(10 mins):Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
(Date:7/29/2015)... Station, TX (PRWEB) , ... July 29, 2015 ... ... POD® designer, manufacturer and supplier, announces the launch of their 2nd generation cell ... to the current miniPOD CT, but it also represents a new POD® design. ...
(Date:7/29/2015)... 29, 2015  AmnioChor Inc., an early stage biotech ... pleased to announce that the Musculoskeletal Transplant Foundation of ... invest in their seed round of development of the ... capabilities. AmnioChor,s technology allows cryopreservation of ... stem cells living within those tissues. Amnion is a ...
(Date:7/29/2015)...  Indivior PLC (LON: INDV) today announced that the ... accepted and received Priority Review by the U.S. Food ... overdose. This naloxone nasal spray comes as a pre-filled ... into the nasal mucosa. 1 The device has ... be better equipped to help an opioid overdose victim. ...
(Date:7/29/2015)... QUEBEC CITY , July 29, 2015 /PRNewswire/ ... (the "Company") today announced it has selected an optimized ... important milestone in the development of a new ... The MAPK pathway represents a prime target for ... significant antitumor activities and survival benefits for B-Raf ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
Cached News: